Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 19 - 20: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
imported>GxPlexBot
Import from GxPlex Excel
m 1 revision imported
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
|has_document=Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
|RefScope=HM
|module=1
|RefDocPart=Article 19 - 20
|unit=1.5.4
|RefLanguage=EN
|scope=HM
|RefTags=TAG-00059-Reg-lat ++ TAG-00013-Adv-art ++ TAG-00008-Cli-ngK ++ TAG-00001-Med-rzn
|doc_part=Article 19 - 20
|RefModule=1
|language=EN
|RefUnit=1.5.4
|entry_by=Florian Adragna
}}
|contributors=
 
|tags=TAG-00059-Reg-lat ++ TAG-00013-Adv-art ++ TAG-00008-Cli-ngK ++ TAG-00001-Med-rzn
{{:Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004}}
|tags_display=[[Glossary:TAG-00059-Reg-lat|Regulatory submission]], [[Glossary:TAG-00013-Adv-art|Advanced-therapy IMP]], [[Glossary:TAG-00008-Cli-ngK|Clinical trial]], [[Glossary:TAG-00001-Med-rzn|Medicinal product]]
 
|comment=Authorisation procedure for gene therapy medicinal products
{| class="wikitable gplx-infobox"
|content=Authorisation procedure for clinical trials involving medicinal products for gene therapy etc.
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 1 — Unit 1.5.4
|-
! Scope
| HM
|-
! Document part
| Article 19 - 20
|-
! Language
| EN
|-
! Original entry by
| Florian Adragna
|-
! Contributors
|
|-
! Tags
| [[Glossary:TAG-00059-Reg-lat|Regulatory submission]], [[Glossary:TAG-00013-Adv-art|Advanced-therapy IMP]], [[Glossary:TAG-00008-Cli-ngK|Clinical trial]], [[Glossary:TAG-00001-Med-rzn|Medicinal product]]
|-
! Comment
| Authorisation procedure for gene therapy medicinal products
|}
 
== Content ==
Authorisation procedure for clinical trials involving medicinal products for gene therapy etc.
[…]
[…]
Authorisation procedure for clinical trials involving medicinal products with special characteristics
Authorisation procedure for clinical trials involving medicinal products with special characteristics
[...]
[...]
}}

Latest revision as of 13:49, 16 July 2026



Document information
Reference GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
Validity area GBR
Scope(s) HM
Document name The Medicines for Human Use (Clinical Trials) Regulations 2004
Version / Revision 01-May-2004
Status Current
Document type Legal act
Language(s) EN
Description The Medicines for Human Use (Clinical Trials) Regulations 2004
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 1 — Unit 1.5.4
Scope HM
Document part Article 19 - 20
Language EN
Original entry by Florian Adragna
Contributors
Tags Regulatory submission, Advanced-therapy IMP, Clinical trial, Medicinal product

Content

Authorisation procedure for clinical trials involving medicinal products for gene therapy etc. […] Authorisation procedure for clinical trials involving medicinal products with special characteristics [...]

Retrieved from "https://gxplex.org/index.php?title=Reference:GBR_The_Medicines_for_Human_Use_(Clinical_Trials)_Regulations_2004_01-May-2004_Article_19_-_20&oldid=17749"